Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

MYELOMAOP 04
UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE MYELOMA (MM)
Ozgur PEKTAS1, Philippe MOREAU2, Meletios-Athanasios DIMOPOULOS3, Joseph MIKHAEL4, Kwee YONG5, Marcelo CAPRA6, Thierry FACON7, Roman HAJEK8, Ivan ŠPIČKA9, France CASCA10, Sandrine MACÉ11, Marie-Laure RISSE12, Thomas MARTIN13
1 Sanofi, Istanbul, Turkey
2 Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
3 Department of Clinical Therapeutics, The National and Kapodistrian University of Athens, Athens, Greece
4 Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA
5 Department of Hematology, University College Hospital, London, UK
6 Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
7 Department of Hematology, Lille University Hospital, Lille, France
8 Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
9 1st Department of Medicine, Department of Hematology, 1st Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
10 Ividata Life Science, Levallois-Perret, France, contracted by Sanofi
11 Sanofi, R&D Translational Medicine, Chilly-Mazarin, France
12 Sanofi, R&D, Vitry-sur-Seine, France
13 Department of Hematology, University of California at San Francisco, San Francisco, CA, USA
Ver más
Lido
1304
Vezes
que se leu este artigo
513
Total PDF
791
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 6 17 3 20
2025 5 48 12 60
2025 4 43 13 56
2025 3 52 16 68
2025 2 38 19 57
2025 1 28 14 42
2024 12 28 16 44
2024 11 46 16 62
2024 10 36 18 54
2024 9 42 16 58
2024 8 29 16 45
2024 7 28 23 51
2024 6 36 24 60
2024 5 28 18 46
2024 4 29 15 44
2024 3 18 17 35
2024 2 22 24 46
2024 1 30 14 44
2023 12 24 14 38
2023 11 14 21 35
2023 10 9 19 28
2023 9 13 23 36
2023 8 8 11 19
2023 7 12 11 23
2023 6 18 14 32
2023 5 15 10 25
2023 4 12 7 19
2023 3 11 11 22
2023 2 10 15 25
2023 1 9 13 22
2022 12 17 26 43
2022 11 11 9 20
2022 10 10 15 25
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy